Why is Takeda Pharmaceutical Company Limited (TAK) up today (0.00%)?
Educational Guide:Analyst Ratings & Target Valuation Guide →
Diplyzer AI Agent• TAK AI Analysis
TAK
NYSEHealthcareTakeda Pharmaceutical Company Limited
$18.03
+0.00 (+0.00%)• Rating: B
Day Range
17.96 - 18.11
52W Range
12.99 - 18.90
Market Cap
$57.37B
Volume
1.80M
Takeda Pharmaceutical Company Limited (TAK) completed a Belt-hold pattern on 25 Aug 2026 trading at $18.03 (+0.00% last session, +1.6% over 1M). Overall financial health rating sits at B.
Key AI Agent Insights
- Financial Health: Takeda Pharmaceutical Company Limited reported a P/E ratio of -91.0 and ROE of -0.3% in its quarterly Q4 financial report dated 31 Mar 2026.(Learn about Financial Ratios & Health →)
- Analyst Consensus: Wall Street analysts maintain a Buy consensus rating on Takeda Pharmaceutical Company Limited. Most recently, TD Cowen maintained its rating to Outperform on 16 May 2023.(Learn about Analyst Ratings →)
- Insider Activity: Corporate insiders recorded 0 purchases and 10 sales in TAK, with the latest Form 4 filing executed on 19 Aug 2026. In Congress, Rep. Virginia Foxx reported a sale in TAK ($15,001 - $50,000) executed on 29 Aug 2023 (disclosed 5 Sept 2023).(Learn about Insider Trading & Disclosures →)
- Technical Pattern Setup: Takeda Pharmaceutical Company Limited chart analysis shows a Belt-hold pattern detected on 25 Aug 2026, establishing a Neutral technical bias.(Learn about Technical Chart Patterns →)